{"transactions":[{"id":1929903,"issuer":{"id":111987,"kind":"organization","name":"Acorda Therapeutics, Inc.","symbol":"ACOR"},"owners":[{"id":114794,"kind":"person","name":"Belloff Neil S.","position":1,"cik":"0001741670","reported_name":"Belloff Neil S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel and Corp Secy"}}],"security":"Employee Stock Option (right to buy)","published_at":"2023-04-04T16:38:58.000Z","date":"2023-03-31","kind":"grant","planned":false,"acquired":true,"shares":77300,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Options issued under the Issuer's 2015 Omnibus Incentive Compensation Plan. The shares subject to the options vest in equal quarterly installments over two years beginning on January 1, 2023 with the first quarterly installment vesting on April 1, 2023."}],"balance_after":77300,"derivative":{"exercise_price":0.586,"expiration_date":"2033-03-31","underlying":"Common Stock","underlying_shares":77300},"source":{"system":"sec-edgar","filing":"0001209191-23-022749","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1008848/000120919123022749/doc4.xml","form_type":"4"}},{"id":2520243,"issuer":{"id":111987,"kind":"organization","name":"Acorda Therapeutics, Inc.","symbol":"ACOR"},"owners":[{"id":114794,"kind":"person","name":"Belloff Neil S.","position":1,"cik":"0001741670","reported_name":"Belloff Neil S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Employee Stock Option (right to buy)","published_at":"2021-11-09T19:03:09.000Z","date":"2021-11-08","kind":"grant","acquired":true,"shares":85000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Options issued under the issuer's 2016 Inducement Plan.  Twenty-five percent of the shares subject to the options vest on November 8, 2022. The balance of the shares vest in equal quarterly installments over the three years thereafter."}],"balance_after":85000,"derivative":{"exercise_price":3.74,"expiration_date":"2031-11-08","underlying":"Common Stock","underlying_shares":85000},"source":{"system":"sec-edgar","filing":"0001209191-21-063723","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1008848/000120919121063723/doc4.xml","form_type":"4"}},{"id":2621533,"issuer":{"id":7180,"kind":"organization","name":"Eloxx Pharmaceuticals, Inc."},"owners":[{"id":114794,"kind":"person","name":"Belloff Neil S.","position":1,"cik":"0001741670","reported_name":"Belloff Neil S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COO, GENERAL COUNSEL &CORP SEC"}}],"security":"Restricted Stock Units","published_at":"2021-07-31T00:32:44.000Z","date":"2021-07-30","kind":"exercise","acquired":false,"shares":1563,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The restricted stock units issued to the reporting person onJanuary 30, 2019 have partially vested and settled for shares of the Issuer's common stock."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The restricted stock units were issued pursuant to the Issuer's 2018 Equity Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The restricted stock units issued to the reporting person onJanuary 30, 2019 have partially vested and settled for shares of the Issuer's common stock."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The restricted stock units issued to the reporting person onJanuary 30, 2019 have partially vested and settled for shares of the Issuer's common stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"The remaining restricted stock units will vest ratably each quarter through January 30, 2023, subject to the reporting person's continued employment with the Issuer, which vesting may be accelerated with certain qualifying terminations of service or in connection with a corporate transaction."}],"balance_after":9375,"derivative":{"underlying":"Common Stock","underlying_shares":1563},"source":{"system":"sec-edgar","filing":"0001415889-21-003750","document":"form4-07302021_050735.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1035354/000141588921003750/form4-07302021_050735.xml","form_type":"4"}},{"id":2621532,"issuer":{"id":7180,"kind":"organization","name":"Eloxx Pharmaceuticals, Inc."},"owners":[{"id":114794,"kind":"person","name":"Belloff Neil S.","position":1,"cik":"0001741670","reported_name":"Belloff Neil S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COO, GENERAL COUNSEL &CORP SEC"}}],"security":"Common Stock","published_at":"2021-07-31T00:32:44.000Z","date":"2021-07-30","kind":"tax_withholding","acquired":false,"shares":459,"price":1.32,"value":605.88,"ownership":{"direct":true},"balance_after":32699,"source":{"system":"sec-edgar","filing":"0001415889-21-003750","document":"form4-07302021_050735.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1035354/000141588921003750/form4-07302021_050735.xml","form_type":"4"}},{"id":2621531,"issuer":{"id":7180,"kind":"organization","name":"Eloxx Pharmaceuticals, Inc."},"owners":[{"id":114794,"kind":"person","name":"Belloff Neil S.","position":1,"cik":"0001741670","reported_name":"Belloff Neil S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COO, GENERAL COUNSEL &CORP SEC"}}],"security":"Common Stock","published_at":"2021-07-31T00:32:44.000Z","date":"2021-07-30","kind":"exercise","acquired":true,"shares":1563,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The restricted stock units issued to the reporting person onJanuary 30, 2019 have partially vested and settled for shares of the Issuer's common stock."}],"balance_after":33158,"source":{"system":"sec-edgar","filing":"0001415889-21-003750","document":"form4-07302021_050735.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1035354/000141588921003750/form4-07302021_050735.xml","form_type":"4"}},{"id":2695733,"issuer":{"id":7180,"kind":"organization","name":"Eloxx Pharmaceuticals, Inc."},"owners":[{"id":114794,"kind":"person","name":"Belloff Neil S.","position":1,"cik":"0001741670","reported_name":"Belloff Neil S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COO, GENERAL COUNSEL &CORP SEC"}}],"security":"Restricted Stock Units","published_at":"2021-05-26T20:10:14.000Z","date":"2021-05-25","kind":"exercise","acquired":false,"shares":6250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The restricted stock units issued to the reporting person on February 25, 2020 have partially vested and settled for shares of the Issuer's common stock."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The restricted stock units were issued pursuant to the Issuer's 2018 Equity Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The restricted stock units issued to the reporting person on February 25, 2020 have partially vested and settled for shares of the Issuer's common stock."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The restricted stock units issued to the reporting person on February 25, 2020 have partially vested and settled for shares of the Issuer's common stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"The remaining restricted stock units will vest ratably each quarter through February 25, 2024, subject to the reporting person's continued employment with the Issuer, which vesting may be accelerated in certain circumstances."}],"balance_after":68750,"derivative":{"underlying":"Common Stock","underlying_shares":6250},"source":{"system":"sec-edgar","filing":"0001415889-21-002682","document":"form4-05262021_040501.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1035354/000141588921002682/form4-05262021_040501.xml","form_type":"4"}},{"id":2695732,"issuer":{"id":7180,"kind":"organization","name":"Eloxx Pharmaceuticals, Inc."},"owners":[{"id":114794,"kind":"person","name":"Belloff Neil S.","position":1,"cik":"0001741670","reported_name":"Belloff Neil S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COO, GENERAL COUNSEL &CORP SEC"}}],"security":"Common Stock","published_at":"2021-05-26T20:10:14.000Z","date":"2021-05-25","kind":"tax_withholding","acquired":false,"shares":1835,"price":1.39,"value":2550.65,"ownership":{"direct":true},"balance_after":31595,"source":{"system":"sec-edgar","filing":"0001415889-21-002682","document":"form4-05262021_040501.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1035354/000141588921002682/form4-05262021_040501.xml","form_type":"4"}},{"id":2695731,"issuer":{"id":7180,"kind":"organization","name":"Eloxx Pharmaceuticals, Inc."},"owners":[{"id":114794,"kind":"person","name":"Belloff Neil S.","position":1,"cik":"0001741670","reported_name":"Belloff Neil S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COO, GENERAL COUNSEL &CORP SEC"}}],"security":"Common Stock","published_at":"2021-05-26T20:10:14.000Z","date":"2021-05-25","kind":"exercise","acquired":true,"shares":6250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The restricted stock units issued to the reporting person on February 25, 2020 have partially vested and settled for shares of the Issuer's common stock."}],"balance_after":33430,"source":{"system":"sec-edgar","filing":"0001415889-21-002682","document":"form4-05262021_040501.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1035354/000141588921002682/form4-05262021_040501.xml","form_type":"4"}},{"id":2733298,"issuer":{"id":7180,"kind":"organization","name":"Eloxx Pharmaceuticals, Inc."},"owners":[{"id":114794,"kind":"person","name":"Belloff Neil S.","position":1,"cik":"0001741670","reported_name":"Belloff Neil S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COO, GENERAL COUNSEL &CORP SEC"}}],"security":"Restricted Stock Units","published_at":"2021-05-03T14:15:12.000Z","date":"2021-04-30","kind":"exercise","acquired":false,"shares":1562,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The restricted stock units issued to the reporting person on January 30, 2019 have partially vested and settled for shares of the Issuer's common stock."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The restricted stock units were issued pursuant to the Issuer's 2018 Equity Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The restricted stock units issued to the reporting person on January 30, 2019 have partially vested and settled for shares of the Issuer's common stock."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The restricted stock units issued to the reporting person on January 30, 2019 have partially vested and settled for shares of the Issuer's common stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"The remaining restricted stock units will vest ratably each quarter through January 30, 2023, subject to the reporting person's continued employment with the Issuer, which vesting may be accelerated with certain qualifying terminations of service or in connection with a corporate transaction."}],"balance_after":10938,"derivative":{"underlying":"Common Stock","underlying_shares":1562},"source":{"system":"sec-edgar","filing":"0001415889-21-002227","document":"form4-05032021_100502.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1035354/000141588921002227/form4-05032021_100502.xml","form_type":"4"}},{"id":2733297,"issuer":{"id":7180,"kind":"organization","name":"Eloxx Pharmaceuticals, Inc."},"owners":[{"id":114794,"kind":"person","name":"Belloff Neil S.","position":1,"cik":"0001741670","reported_name":"Belloff Neil S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COO, GENERAL COUNSEL &CORP SEC"}}],"security":"Common Stock","published_at":"2021-05-03T14:15:12.000Z","date":"2021-04-30","kind":"tax_withholding","acquired":false,"shares":459,"price":2.18,"value":1000.62,"ownership":{"direct":true},"balance_after":27180,"source":{"system":"sec-edgar","filing":"0001415889-21-002227","document":"form4-05032021_100502.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1035354/000141588921002227/form4-05032021_100502.xml","form_type":"4"}},{"id":2733296,"issuer":{"id":7180,"kind":"organization","name":"Eloxx Pharmaceuticals, Inc."},"owners":[{"id":114794,"kind":"person","name":"Belloff Neil S.","position":1,"cik":"0001741670","reported_name":"Belloff Neil S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COO, GENERAL COUNSEL &CORP SEC"}}],"security":"Common Stock","published_at":"2021-05-03T14:15:12.000Z","date":"2021-04-30","kind":"exercise","acquired":true,"shares":1562,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The restricted stock units issued to the reporting person on January 30, 2019 have partially vested and settled for shares of the Issuer's common stock."}],"balance_after":27639,"source":{"system":"sec-edgar","filing":"0001415889-21-002227","document":"form4-05032021_100502.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1035354/000141588921002227/form4-05032021_100502.xml","form_type":"4"}},{"id":2830214,"issuer":{"id":7180,"kind":"organization","name":"Eloxx Pharmaceuticals, Inc."},"owners":[{"id":114794,"kind":"person","name":"Belloff Neil S.","position":1,"cik":"0001741670","reported_name":"Belloff Neil S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COO, GENERAL COUNSEL &CORP SEC"}}],"security":"Restricted Stock Units","published_at":"2021-02-27T00:05:35.000Z","date":"2021-02-25","kind":"exercise","acquired":false,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The restricted stock units issued to the reporting person on February 25, 2020 have partially vested and settled for shares of the Issuer's common stock."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The restricted stock units were issued pursuant to the Issuer's 2018 Equity Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The restricted stock units issued to the reporting person on February 25, 2020 have partially vested and settled for shares of the Issuer's common stock."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The restricted stock units issued to the reporting person on February 25, 2020 have partially vested and settled for shares of the Issuer's common stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"The remaining restricted stock units will vest ratably each quarter through February 25, 2024, subject to the reporting person's continued employment with the Issuer, which vesting may be accelerated in certain circumstances."}],"balance_after":75000,"derivative":{"underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001415889-21-001001","document":"form4-02262021_070206.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1035354/000141588921001001/form4-02262021_070206.xml","form_type":"4"}},{"id":2830213,"issuer":{"id":7180,"kind":"organization","name":"Eloxx Pharmaceuticals, Inc."},"owners":[{"id":114794,"kind":"person","name":"Belloff Neil S.","position":1,"cik":"0001741670","reported_name":"Belloff Neil S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COO, GENERAL COUNSEL &CORP SEC"}}],"security":"Common Stock","published_at":"2021-02-27T00:05:35.000Z","date":"2021-02-25","kind":"tax_withholding","acquired":false,"shares":7338,"price":3.95,"value":28985.1,"ownership":{"direct":true},"balance_after":26077,"source":{"system":"sec-edgar","filing":"0001415889-21-001001","document":"form4-02262021_070206.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1035354/000141588921001001/form4-02262021_070206.xml","form_type":"4"}},{"id":2830212,"issuer":{"id":7180,"kind":"organization","name":"Eloxx Pharmaceuticals, Inc."},"owners":[{"id":114794,"kind":"person","name":"Belloff Neil S.","position":1,"cik":"0001741670","reported_name":"Belloff Neil S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COO, GENERAL COUNSEL &CORP SEC"}}],"security":"Common Stock","published_at":"2021-02-27T00:05:35.000Z","date":"2021-02-25","kind":"exercise","acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The restricted stock units issued to the reporting person on February 25, 2020 have partially vested and settled for shares of the Issuer's common stock."}],"balance_after":33415,"source":{"system":"sec-edgar","filing":"0001415889-21-001001","document":"form4-02262021_070206.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1035354/000141588921001001/form4-02262021_070206.xml","form_type":"4"}},{"id":2855596,"issuer":{"id":7180,"kind":"organization","name":"Eloxx Pharmaceuticals, Inc."},"owners":[{"id":114794,"kind":"person","name":"Belloff Neil S.","position":1,"cik":"0001741670","reported_name":"Belloff Neil S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COO, GENERAL COUNSEL &CORP SEC"}}],"security":"Stock Options","published_at":"2021-02-17T23:40:04.000Z","date":"2021-02-12","kind":"grant","acquired":true,"shares":120000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The stock options were issued pursuant to the Issuer's 2018 Equity Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock options were issued pursuant to the Issuer's 2018 Equity Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The options vest and become exercisable over a four-year period, with one-fourth of the shares of common stock underlying the options vesting on February 12, 2022, and the remainder vesting in twelve equal quarterly installments thereafter."}],"balance_after":120000,"derivative":{"exercise_price":4.04,"expiration_date":"2031-02-12","underlying":"Common Stock","underlying_shares":120000},"source":{"system":"sec-edgar","filing":"0001415889-21-000735","document":"form4-02172021_030226.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1035354/000141588921000735/form4-02172021_030226.xml","form_type":"4"}},{"id":2886479,"issuer":{"id":7180,"kind":"organization","name":"Eloxx Pharmaceuticals, Inc."},"owners":[{"id":114794,"kind":"person","name":"Belloff Neil S.","position":1,"cik":"0001741670","reported_name":"Belloff Neil S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COO, GENERAL COUNSEL &CORP SEC"}}],"security":"Restricted Stock Units","published_at":"2021-02-02T21:10:43.000Z","date":"2021-01-30","kind":"exercise","acquired":false,"shares":1563,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The restricted stock units issued to the reporting person on January 30, 2019 have partially vested and settled for shares of the Issuer's common stock."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The restricted stock units were issued pursuant to the Issuer's 2018 Equity Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The restricted stock units issued to the reporting person on January 30, 2019 have partially vested and settled for shares of the Issuer's common stock."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The restricted stock units issued to the reporting person on January 30, 2019 have partially vested and settled for shares of the Issuer's common stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"The remaining restricted stock units will vest ratably each quarter through January 30, 2023, subject to the reporting person's continued employment with the Issuer, which vesting may be accelerated in certain circumstances."}],"balance_after":12500,"derivative":{"underlying":"Common Stock","underlying_shares":1563},"source":{"system":"sec-edgar","filing":"0001415889-21-000501","document":"form4-02022021_040201.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1035354/000141588921000501/form4-02022021_040201.xml","form_type":"4"}},{"id":2886478,"issuer":{"id":7180,"kind":"organization","name":"Eloxx Pharmaceuticals, Inc."},"owners":[{"id":114794,"kind":"person","name":"Belloff Neil S.","position":1,"cik":"0001741670","reported_name":"Belloff Neil S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COO, GENERAL COUNSEL &CORP SEC"}}],"security":"Common Stock","published_at":"2021-02-02T21:10:43.000Z","date":"2021-01-30","kind":"tax_withholding","acquired":false,"shares":542,"price":3.44,"value":1864.48,"ownership":{"direct":true},"balance_after":8415,"source":{"system":"sec-edgar","filing":"0001415889-21-000501","document":"form4-02022021_040201.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1035354/000141588921000501/form4-02022021_040201.xml","form_type":"4"}},{"id":2886477,"issuer":{"id":7180,"kind":"organization","name":"Eloxx Pharmaceuticals, Inc."},"owners":[{"id":114794,"kind":"person","name":"Belloff Neil S.","position":1,"cik":"0001741670","reported_name":"Belloff Neil S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COO, GENERAL COUNSEL &CORP SEC"}}],"security":"Common Stock","published_at":"2021-02-02T21:10:43.000Z","date":"2021-01-30","kind":"exercise","acquired":true,"shares":1563,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The restricted stock units issued to the reporting person on January 30, 2019 have partially vested and settled for shares of the Issuer's common stock."}],"balance_after":8957,"source":{"system":"sec-edgar","filing":"0001415889-21-000501","document":"form4-02022021_040201.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1035354/000141588921000501/form4-02022021_040201.xml","form_type":"4"}},{"id":2996702,"issuer":{"id":7180,"kind":"organization","name":"Eloxx Pharmaceuticals, Inc."},"owners":[{"id":114794,"kind":"person","name":"Belloff Neil S.","position":1,"cik":"0001741670","reported_name":"Belloff Neil S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COO, GENERAL COUNSEL &CORP SEC"}}],"security":"Restricted Stock Units","published_at":"2020-11-02T21:20:45.000Z","date":"2020-10-30","kind":"exercise","acquired":false,"shares":1562,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The restricted stock units issued to the reporting person on January 30, 2019 have partially vested and settled for shares of the Issuer's common stock."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The restricted stock units were issued pursuant to the Issuer's 2018 Equity Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The restricted stock units issued to the reporting person on January 30, 2019 have partially vested and settled for shares of the Issuer's common stock."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The restricted stock units issued to the reporting person on January 30, 2019 have partially vested and settled for shares of the Issuer's common stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"The remaining restricted stock units will vest ratably each quarter through January 30, 2023, subject to the reporting person's continued employment with the Issuer, which vesting may be accelerated in certain circumstances."}],"balance_after":14063,"derivative":{"underlying":"Common Stock","underlying_shares":1562},"source":{"system":"sec-edgar","filing":"0001415889-20-002520","document":"form4-11022020_041102.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1035354/000141588920002520/form4-11022020_041102.xml","form_type":"4"}},{"id":2996701,"issuer":{"id":7180,"kind":"organization","name":"Eloxx Pharmaceuticals, Inc."},"owners":[{"id":114794,"kind":"person","name":"Belloff Neil S.","position":1,"cik":"0001741670","reported_name":"Belloff Neil S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COO, GENERAL COUNSEL &CORP SEC"}}],"security":"Common Stock","published_at":"2020-11-02T21:20:45.000Z","date":"2020-10-30","kind":"tax_withholding","acquired":false,"shares":459,"price":2.53,"value":1161.27,"ownership":{"direct":true},"balance_after":7394,"source":{"system":"sec-edgar","filing":"0001415889-20-002520","document":"form4-11022020_041102.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1035354/000141588920002520/form4-11022020_041102.xml","form_type":"4"}},{"id":2996700,"issuer":{"id":7180,"kind":"organization","name":"Eloxx Pharmaceuticals, Inc."},"owners":[{"id":114794,"kind":"person","name":"Belloff Neil S.","position":1,"cik":"0001741670","reported_name":"Belloff Neil S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COO, GENERAL COUNSEL &CORP SEC"}}],"security":"Common Stock","published_at":"2020-11-02T21:20:45.000Z","date":"2020-10-30","kind":"exercise","acquired":true,"shares":1562,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The restricted stock units issued to the reporting person on January 30, 2019 have partially vested and settled for shares of the Issuer's common stock."}],"balance_after":7853,"source":{"system":"sec-edgar","filing":"0001415889-20-002520","document":"form4-11022020_041102.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1035354/000141588920002520/form4-11022020_041102.xml","form_type":"4"}},{"id":3072703,"issuer":{"id":7180,"kind":"organization","name":"Eloxx Pharmaceuticals, Inc."},"owners":[{"id":114794,"kind":"person","name":"Belloff Neil S.","position":1,"cik":"0001741670","reported_name":"Belloff Neil S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COO, GENERAL COUNSEL &CORP SEC"}}],"security":"Restricted Stock Units","published_at":"2020-07-31T20:10:18.000Z","date":"2020-07-30","kind":"exercise","acquired":false,"shares":1563,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The restricted stock units issued to the reporting person on January 30, 2019 have partially vested and settled for shares of the Issuer's common stock."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The restricted stock units were issued pursuant to the Issuer's 2018 Equity Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The restricted stock units issued to the reporting person on January 30, 2019 have partially vested and settled for shares of the Issuer's common stock."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The restricted stock units issued to the reporting person on January 30, 2019 have partially vested and settled for shares of the Issuer's common stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"The remaining restricted stock units will vest ratably each quarter through January 30, 2023, subject to the reporting person's continued employment with the Issuer, which vesting may be accelerated in certain circumstances."}],"balance_after":15625,"derivative":{"underlying":"Common Stock","underlying_shares":1563},"source":{"system":"sec-edgar","filing":"0001415889-20-001981","document":"form4-07312020_040707.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1035354/000141588920001981/form4-07312020_040707.xml","form_type":"4"}},{"id":3072702,"issuer":{"id":7180,"kind":"organization","name":"Eloxx Pharmaceuticals, Inc."},"owners":[{"id":114794,"kind":"person","name":"Belloff Neil S.","position":1,"cik":"0001741670","reported_name":"Belloff Neil S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COO, GENERAL COUNSEL &CORP SEC"}}],"security":"Common Stock","published_at":"2020-07-31T20:10:18.000Z","date":"2020-07-30","kind":"tax_withholding","acquired":false,"shares":459,"price":2.84,"value":1303.56,"ownership":{"direct":true},"balance_after":6291,"source":{"system":"sec-edgar","filing":"0001415889-20-001981","document":"form4-07312020_040707.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1035354/000141588920001981/form4-07312020_040707.xml","form_type":"4"}},{"id":3072701,"issuer":{"id":7180,"kind":"organization","name":"Eloxx Pharmaceuticals, Inc."},"owners":[{"id":114794,"kind":"person","name":"Belloff Neil S.","position":1,"cik":"0001741670","reported_name":"Belloff Neil S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COO, GENERAL COUNSEL &CORP SEC"}}],"security":"Common Stock","published_at":"2020-07-31T20:10:18.000Z","date":"2020-07-30","kind":"exercise","acquired":true,"shares":1563,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The restricted stock units issued to the reporting person on January 30, 2019 have partially vested and settled for shares of the Issuer's common stock."}],"balance_after":6750,"source":{"system":"sec-edgar","filing":"0001415889-20-001981","document":"form4-07312020_040707.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1035354/000141588920001981/form4-07312020_040707.xml","form_type":"4"}},{"id":3165602,"issuer":{"id":7180,"kind":"organization","name":"Eloxx Pharmaceuticals, Inc."},"owners":[{"id":114794,"kind":"person","name":"Belloff Neil S.","position":1,"cik":"0001741670","reported_name":"Belloff Neil S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COO, GENERAL COUNSEL &CORP SEC"}}],"security":"Restricted Stock Units","published_at":"2020-05-01T21:20:15.000Z","date":"2020-04-30","kind":"exercise","acquired":false,"shares":1562,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The restricted stock units issued to the reporting person on January 30, 2019 have partially vested and settled for shares of the Issuer's common stock."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The restricted stock units were issued pursuant to the Issuer's 2018 Equity Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The restricted stock units issued to the reporting person on January 30, 2019 have partially vested and settled for shares of the Issuer's common stock."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The restricted stock units issued to the reporting person on January 30, 2019 have partially vested and settled for shares of the Issuer's common stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"The remaining restricted stock units will vest ratably each quarter through January 30, 2023, subject to the reporting person's continued employment with the Issuer, which vesting may be accelerated in certain circumstances."}],"balance_after":17188,"derivative":{"underlying":"Common Stock","underlying_shares":1562},"source":{"system":"sec-edgar","filing":"0001415889-20-001104","document":"form4-05012020_050501.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1035354/000141588920001104/form4-05012020_050501.xml","form_type":"4"}},{"id":3165601,"issuer":{"id":7180,"kind":"organization","name":"Eloxx Pharmaceuticals, Inc."},"owners":[{"id":114794,"kind":"person","name":"Belloff Neil S.","position":1,"cik":"0001741670","reported_name":"Belloff Neil S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COO, GENERAL COUNSEL &CORP SEC"}}],"security":"Common Stock","published_at":"2020-05-01T21:20:15.000Z","date":"2020-04-30","kind":"tax_withholding","acquired":false,"shares":459,"price":2.92,"value":1340.28,"ownership":{"direct":true},"balance_after":5187,"source":{"system":"sec-edgar","filing":"0001415889-20-001104","document":"form4-05012020_050501.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1035354/000141588920001104/form4-05012020_050501.xml","form_type":"4"}},{"id":3165600,"issuer":{"id":7180,"kind":"organization","name":"Eloxx Pharmaceuticals, Inc."},"owners":[{"id":114794,"kind":"person","name":"Belloff Neil S.","position":1,"cik":"0001741670","reported_name":"Belloff Neil S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COO, GENERAL COUNSEL &CORP SEC"}}],"security":"Common Stock","published_at":"2020-05-01T21:20:15.000Z","date":"2020-04-30","kind":"exercise","acquired":true,"shares":1562,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The restricted stock units issued to the reporting person on January 30, 2019 have partially vested and settled for shares of the Issuer's common stock."}],"balance_after":5646,"source":{"system":"sec-edgar","filing":"0001415889-20-001104","document":"form4-05012020_050501.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1035354/000141588920001104/form4-05012020_050501.xml","form_type":"4"}},{"id":3228309,"issuer":{"id":7180,"kind":"organization","name":"Eloxx Pharmaceuticals, Inc."},"owners":[{"id":114794,"kind":"person","name":"Belloff Neil S.","position":1,"cik":"0001741670","reported_name":"Belloff Neil S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COO, GENERAL COUNSEL &CORP SEC"}}],"security":"Restricted Stock Units","published_at":"2020-03-04T19:30:31.000Z","date":"2020-01-30","kind":"exercise","acquired":false,"shares":6250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Reflects the restricted stock units issued to the reporting person on January 30, 2019 which have partially vested and settled for shares of the issuer's common stock.\nThe original Form 4 filed on January 31, 2020 is amended in its entirety by this Form 4 Amendment to provide the: (a) correct date the restricted stock units were first issued to the reporting person; and (b) correct disposition of the derivative securities."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."},{"field":"shares","element":"transactionShares","label":"F3","text":"The original Form 4 filed on January 31, 2020 is amended by this Form 4 Amendment to correctly identify the nature of the transaction of the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The restricted stock units were issued pursuant to the Issuer's 2018 Equity Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Reflects the restricted stock units issued to the reporting person on January 30, 2019 which have partially vested and settled for shares of the issuer's common stock.\nThe original Form 4 filed on January 31, 2020 is amended in its entirety by this Form 4 Amendment to provide the: (a) correct date the restricted stock units were first issued to the reporting person; and (b) correct disposition of the derivative securities."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Reflects the restricted stock units issued to the reporting person on January 30, 2019 which have partially vested and settled for shares of the issuer's common stock.\nThe original Form 4 filed on January 31, 2020 is amended in its entirety by this Form 4 Amendment to provide the: (a) correct date the restricted stock units were first issued to the reporting person; and (b) correct disposition of the derivative securities."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F5","text":"The remaining restricted stock units will vest ratably each quarter through January 30, 2023, subject to the reporting person's continued employment with the Issuer, which vesting may be accelerated in certain circumstances."}],"balance_after":18750,"derivative":{"underlying":"Common Stock","underlying_shares":6250},"source":{"system":"sec-edgar","filing":"0001415889-20-000639","document":"form4a-03042020_020316.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1035354/000141588920000639/form4a-03042020_020316.xml","form_type":"4/A","original_submission_date":"2020-01-31"}},{"id":3228308,"issuer":{"id":7180,"kind":"organization","name":"Eloxx Pharmaceuticals, Inc."},"owners":[{"id":114794,"kind":"person","name":"Belloff Neil S.","position":1,"cik":"0001741670","reported_name":"Belloff Neil S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COO, GENERAL COUNSEL &CORP SEC"}}],"security":"Common Stock","published_at":"2020-03-04T19:30:31.000Z","date":"2020-01-30","kind":"tax_withholding","acquired":false,"shares":2166,"price":3.91,"value":8469.06,"ownership":{"direct":true},"balance_after":4084,"source":{"system":"sec-edgar","filing":"0001415889-20-000639","document":"form4a-03042020_020316.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1035354/000141588920000639/form4a-03042020_020316.xml","form_type":"4/A","original_submission_date":"2020-01-31"}},{"id":3228307,"issuer":{"id":7180,"kind":"organization","name":"Eloxx Pharmaceuticals, Inc."},"owners":[{"id":114794,"kind":"person","name":"Belloff Neil S.","position":1,"cik":"0001741670","reported_name":"Belloff Neil S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COO, GENERAL COUNSEL &CORP SEC"}}],"security":"Common Stock","published_at":"2020-03-04T19:30:31.000Z","date":"2020-01-30","kind":"exercise","acquired":true,"shares":6250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Reflects the restricted stock units issued to the reporting person on January 30, 2019 which have partially vested and settled for shares of the issuer's common stock.\nThe original Form 4 filed on January 31, 2020 is amended in its entirety by this Form 4 Amendment to provide the: (a) correct date the restricted stock units were first issued to the reporting person; and (b) correct disposition of the derivative securities."}],"balance_after":6250,"source":{"system":"sec-edgar","filing":"0001415889-20-000639","document":"form4a-03042020_020316.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1035354/000141588920000639/form4a-03042020_020316.xml","form_type":"4/A","original_submission_date":"2020-01-31"}},{"id":3246728,"issuer":{"id":7180,"kind":"organization","name":"Eloxx Pharmaceuticals, Inc."},"owners":[{"id":114794,"kind":"person","name":"Belloff Neil S.","position":1,"cik":"0001741670","reported_name":"Belloff Neil S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COO, GENERAL COUNSEL &CORP SEC"}}],"security":"Restricted Stock Units","published_at":"2020-02-27T00:01:24.000Z","date":"2020-02-25","kind":"grant","acquired":true,"shares":100000,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The restricted stock units were issued pursuant to the Issuer's 2018 Equity Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The restricted stock units will vest as follows: 25% after first anniversary and ratably each quarter over the next three years thereafter subject to the reporting person's continued employment with the Issuer, which vesting may be accelerated in certain circumstances. Vested shares will be delivered promptly after each vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The restricted stock units will vest as follows: 25% after first anniversary and ratably each quarter over the next three years thereafter subject to the reporting person's continued employment with the Issuer, which vesting may be accelerated in certain circumstances. Vested shares will be delivered promptly after each vesting date."}],"balance_after":100000,"derivative":{"underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001415889-20-000500","document":"form4-02262020_040210.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1035354/000141588920000500/form4-02262020_040210.xml","form_type":"4"}},{"id":3246727,"issuer":{"id":7180,"kind":"organization","name":"Eloxx Pharmaceuticals, Inc."},"owners":[{"id":114794,"kind":"person","name":"Belloff Neil S.","position":1,"cik":"0001741670","reported_name":"Belloff Neil S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COO, GENERAL COUNSEL &CORP SEC"}}],"security":"Stock Options","published_at":"2020-02-27T00:01:24.000Z","date":"2020-02-25","kind":"grant","acquired":true,"shares":200000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The option vests and becomes exercisable over a four-year period, with one-fourth of the shares of common stock underlying the options vesting on February 25, 2021, and the remainder vesting in twelve equal quarterly installments thereafter."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock options were issued pursuant to the Issuer's 2018 Equity Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vests and becomes exercisable over a four-year period, with one-fourth of the shares of common stock underlying the options vesting on February 25, 2021, and the remainder vesting in twelve equal quarterly installments thereafter."}],"balance_after":200000,"derivative":{"exercise_price":3.59,"expiration_date":"2030-02-25","underlying":"Common Stock","underlying_shares":200000},"source":{"system":"sec-edgar","filing":"0001415889-20-000500","document":"form4-02262020_040210.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1035354/000141588920000500/form4-02262020_040210.xml","form_type":"4"}},{"id":3296913,"issuer":{"id":7180,"kind":"organization","name":"Eloxx Pharmaceuticals, Inc."},"owners":[{"id":114794,"kind":"person","name":"Belloff Neil S.","position":1,"cik":"0001741670","reported_name":"Belloff Neil S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"GENERAL COUNSEL/CORPORATE SECR"}}],"security":"Restricted Stock Units","published_at":"2020-01-31T22:15:15.000Z","date":"2020-01-30","kind":"exercise","acquired":true,"shares":6250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The restricted stock units issued to the reporting person on January 30, 2020 have partially vested and settled for shares of the Issuer's common stock."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The restricted stock units were issued pursuant to the Issuer's 2018 Equity Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The restricted stock units issued to the reporting person on January 30, 2020 have partially vested and settled for shares of the Issuer's common stock."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The restricted stock units issued to the reporting person on January 30, 2020 have partially vested and settled for shares of the Issuer's common stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"The remaining restricted stock units will vest ratably each quarter through January 30, 2023, subject to the reporting person's continued employment with the Issuer, which vesting may be accelerated in certain circumstances."}],"balance_after":18750,"derivative":{"underlying":"Common Stock","underlying_shares":6250},"source":{"system":"sec-edgar","filing":"0001415889-20-000195","document":"form4-01312020_050102.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1035354/000141588920000195/form4-01312020_050102.xml","form_type":"4"}},{"id":3296912,"issuer":{"id":7180,"kind":"organization","name":"Eloxx Pharmaceuticals, Inc."},"owners":[{"id":114794,"kind":"person","name":"Belloff Neil S.","position":1,"cik":"0001741670","reported_name":"Belloff Neil S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"GENERAL COUNSEL/CORPORATE SECR"}}],"security":"Common Stock","published_at":"2020-01-31T22:15:15.000Z","date":"2020-01-30","kind":"tax_withholding","acquired":false,"shares":2166,"price":3.91,"value":8469.06,"ownership":{"direct":true},"balance_after":4084,"source":{"system":"sec-edgar","filing":"0001415889-20-000195","document":"form4-01312020_050102.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1035354/000141588920000195/form4-01312020_050102.xml","form_type":"4"}},{"id":3296911,"issuer":{"id":7180,"kind":"organization","name":"Eloxx Pharmaceuticals, Inc."},"owners":[{"id":114794,"kind":"person","name":"Belloff Neil S.","position":1,"cik":"0001741670","reported_name":"Belloff Neil S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"GENERAL COUNSEL/CORPORATE SECR"}}],"security":"Common Stock","published_at":"2020-01-31T22:15:15.000Z","date":"2020-01-30","kind":"exercise","acquired":true,"shares":6250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The restricted stock units issued to the reporting person on January 30, 2020 have partially vested and settled for shares of the Issuer's common stock."}],"balance_after":6250,"source":{"system":"sec-edgar","filing":"0001415889-20-000195","document":"form4-01312020_050102.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1035354/000141588920000195/form4-01312020_050102.xml","form_type":"4"}},{"id":3415186,"issuer":{"id":7180,"kind":"organization","name":"Eloxx Pharmaceuticals, Inc."},"owners":[{"id":114794,"kind":"person","name":"Belloff Neil S.","position":1,"cik":"0001741670","reported_name":"Belloff Neil S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"GENERAL COUNSEL/CORPORATE SECR"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2019-09-13T20:10:19.000Z","date":"2019-09-12","kind":"grant","acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The stock options were issued pursuant to the Issuer's 2018 Equity Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests and becomes exercisable over a four-year period, with one-fourth of the shares of common stock underlying the options vesting on September 12, 2020, and the remainder vests in twelve equal quarterly installments thereafter."}],"balance_after":100000,"derivative":{"exercise_price":6.47,"expiration_date":"2029-09-12","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001415889-19-001017","document":"form4-09132019_040906.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1035354/000141588919001017/form4-09132019_040906.xml","form_type":"4"}},{"id":3681478,"issuer":{"id":7180,"kind":"organization","name":"Eloxx Pharmaceuticals, Inc."},"owners":[{"id":114794,"kind":"person","name":"Belloff Neil S.","position":1,"cik":"0001741670","reported_name":"Belloff Neil S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"GENERAL COUNSEL/CORPORATE SECR"}}],"security":"Restricted Stock Units","published_at":"2019-02-01T00:54:43.000Z","date":"2019-01-30","kind":"grant","acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The restricted stock units were issued pursuant to the Issuer's 2018 Equity Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The restricted stock units will vest as follows: 25% after first anniversary and ratably each quarter over the next three years thereafter subject to the reporting person's continued employment with the Issuer, which vesting may be accelerated in certain circumstances. Vested shares will be delivered promptly after each vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The restricted stock units will vest as follows: 25% after first anniversary and ratably each quarter over the next three years thereafter subject to the reporting person's continued employment with the Issuer, which vesting may be accelerated in certain circumstances. Vested shares will be delivered promptly after each vesting date."}],"balance_after":25000,"derivative":{"underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001415889-19-000113","document":"form4-01312019_040128.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1035354/000141588919000113/form4-01312019_040128.xml","form_type":"4"}},{"id":3681477,"issuer":{"id":7180,"kind":"organization","name":"Eloxx Pharmaceuticals, Inc."},"owners":[{"id":114794,"kind":"person","name":"Belloff Neil S.","position":1,"cik":"0001741670","reported_name":"Belloff Neil S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"GENERAL COUNSEL/CORPORATE SECR"}}],"security":"Stock Options","published_at":"2019-02-01T00:54:43.000Z","date":"2019-01-30","kind":"grant","acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The stock options were issued pursuant to the Issuer's 2018 Equity Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests and becomes exercisable over a four-year period, with one-fourth of the shares of common stock underlying the options vesting on January 30, 2020, and the remainder vests in twelve equal quarterly installments thereafter."}],"balance_after":50000,"derivative":{"exercise_price":11.53,"expiration_date":"2029-01-30","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001415889-19-000113","document":"form4-01312019_040128.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1035354/000141588919000113/form4-01312019_040128.xml","form_type":"4"}},{"id":3887314,"issuer":{"id":7180,"kind":"organization","name":"Eloxx Pharmaceuticals, Inc."},"owners":[{"id":114794,"kind":"person","name":"Belloff Neil S.","position":1,"cik":"0001741670","reported_name":"Belloff Neil S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel and Secretary"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2018-06-20T21:34:41.000Z","date":"2018-06-18","kind":"grant","acquired":true,"shares":125000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One third (1/3) of the shares underlying the option shall vest on June 18, 2019 (the \"Cliff Vesting Date\"), the remainder of the grant shall vest in equal installments on each quarterly anniversary of the Cliff Vesting Date, subject to Reporting Person's continuous service as of each such date."}],"balance_after":125000,"derivative":{"exercise_price":20.85,"expiration_date":"2028-06-18","underlying":"Common Stock","underlying_shares":125000},"source":{"system":"sec-edgar","filing":"0001209191-18-038827","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1035354/000120919118038827/doc4.xml","form_type":"4"}}]}